Info Icon
Please note: All Prescription drugs require a prescription from the prescriber prior to shipment.

Vetmedin Solution rx

Vetmedin Solution rx

Limited quantity in stock!

$65.10

The same VETMEDIN treatment you’ve prescribed for your CHF patients for years is also available in a liquid oral solution. Newly available VETMEDIN Solution makes administration easy for dogs who prefer liquid medication and delivers just the right dose they need.

Benefits:

  • VETMEDIN Solution is the only brand approved FDA-approved by the FDA that includes both tablet and liquid formulations to treat dogs with CHF due to MMVD and DCM. Meets FDA standards of product efficacy, stability, and strength.
  • VETMEDIN products have a dual mode of action, relaxing the blood vessels carrying blood to and from the heart, and improving heart muscle function to help the heart work more efficiently.
  • VETMEDIN Solution are indicated for the management of the signs of mild, moderate, or severe congestive heart failure (CHF) in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM).
  • CVIM-Consensus Recommended - American College of Veterinary Internal Medicine (ACVIM) consensus guidelines recommended as a first-line therapy for dogs in heart failure 
  • Easy  administration for dogs who prefer liquid medication and delivers just the right dose they need.

For:

Dogs

Sold As:

1.5 mg/ml 50 ml bottle

Manufacturer:

B.I. 

Caution:

VETMEDIN (pimobendan) should not be administered in cases of hypertrophic cardiomyopathy, aortic stenosis, or any other clinical condition where an augmentation of cardiac output is inappropriate for functional or anatomical reasons. Not for use in humans. Keep this and all medications out of reach of children. Consult a physician in case of accidental ingestion by humans. The safe use of VETMEDIN has not been evaluated in dogs younger than 6 months of age, dogs with congenital heart defects, dogs with diabetes mellitus or other serious metabolic diseases, dogs used for breeding, or pregnant or lactating bitches. Only for use in dogs with clinical evidence of heart failure. At 3 and 5 times the recommended dosage, administered over a 6-month period of time, pimobendan caused an exaggerated hemodynamic response in the normal dog heart, which was associated with cardiac pathology. Keep VETMEDIN in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose.

Adverse Reactions: 

The most common side effects reported in field studies were poor appetite, lethargy, diarrhea, dyspnea, azotemia, weakness, and ataxia. 

Storage Information:

Store at or below 77°F (25°C) with excursions permitted up to 86°F (30°C). Once the bottle is opened, use the contents within 8 weeks.

 

VETMEDIN Solution should be administered orally at a total daily dose of 0.23 mg/lb (0.5 mg/kg) body weight.

 

  • The total daily dose should be divided into 2 equal portions administered approximately 12 hours apart (i.e., morning and evening).       
     
  • VETMEDIN Solution should be administered directly into the mouth. Do not mix into food.       
     
  • VETMEDIN Solution should be administered using the orange dosing syringe provided in the package. The syringe is calibrated to deliver the appropriate morning or evening dose when drawn to the dog’s nearest weight in pounds.       
     
  • Do not shake the bottle before or during use to avoid foaming.     

  • Do not use in Cats or Horses.

Vetmedin Oral Solution:

Pimobendan 1.5 mg/ml in 50 ml bottle

Benefits:

  • VETMEDIN Solution is the only brand approved FDA-approved by the FDA that includes both tablet and liquid formulations to treat dogs with CHF due to MMVD and DCM. Meets FDA standards of product efficacy, stability, and strength
  • VETMEDIN products have a dual mode of action, relaxing the blood vessels carrying blood to and from the heart, and improving heart muscle function to help the heart work more efficiently.
  • VETMEDIN Solution are indicated for the management of the signs of mild, moderate, or severe congestive heart failure (CHF) in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM).
  • CVIM-Consensus Recommended - American College of Veterinary Internal Medicine (ACVIM) consensus guidelines recommended as a first-line therapy for dogs in heart failure 
  • Easy  administration for dogs who prefer liquid medication and delivers just the right dose they need.

Reviews

Write a review

7 other products in the same category:

$65.10